» Articles » PMID: 36983900

Attenuation of Endoplasmic Reticulum Stress Enhances Carvacrol-Induced Apoptosis in Osteosarcoma Cell Lines

Overview
Journal Life (Basel)
Specialty Biology
Date 2023 Mar 29
PMID 36983900
Authors
Affiliations
Soon will be listed here.
Abstract

Carvacrol is a monoterpenoid phenol that has excellent antimicrobial, antiviral, and anti-inflammatory activities. It can also improve wound healing. However, few studies have explored its antitumor effect on osteosarcoma. In this report, we tried to determine the potential efficacy of carvacrol against osteosarcoma cell lines. Our data revealed that carvacrol exposure inhibited the proliferation of osteosarcoma HOS and U-2 OS cells. In addition, carvacrol exposure enhanced the levels of cleaved PARP and caspase 3 and increased annexin V-positive cells, indicating that carvacrol exposure triggers apoptosis in osteosarcoma cell lines. Furthermore, the levels of reactive oxygen species (ROS) were enhanced after carvacrol exposure and cotreatment with NAC, the ROS scavenger, decreased the levels of cleaved PARP and caspase 3, suggesting the involvement of ROS in carvacrol-induced apoptosis. Importantly, we found that carvacrol exposure triggered several protein expressions related to endoplasmic reticulum (ER) stress, including GRP78/Bip, IRE1a, PERK, and CHOP, in HOS and U-2 OS cells, indicating that carvacrol exposure could result in ER stress in these cell lines. Cotreatment with the ER stress inhibitor 4-PBA increased the levels of cleaved PARP and caspase 3 and further suppressed cellular proliferation in carvacrol-exposed osteosarcoma cell lines. Overall, the results indicate that induced ER stress can protect cells from apoptosis, but increased ROS contributes to apoptosis in carvacrol-treated cells. In this report, we first demonstrate the role of ER stress in carvacrol-induced apoptosis and suggest that ER stress could be targeted to enhance the antitumor activity of carvacrol in osteosarcoma cell lines.

Citing Articles

Prominent Naturally Derived Oxidative-Stress-Targeting Drugs and Their Applications in Cancer Treatment.

Lee E, Yang D, Hong J Antioxidants (Basel). 2025; 14(1).

PMID: 39857383 PMC: 11760868. DOI: 10.3390/antiox14010049.


Tongguanteng injection exerts anti-osteosarcoma effects through the ER stress-associated IRE1/CHOP pathway.

Xue X, Zhou Y, Xu L, Wei L, Hu Y, Yang J BMC Complement Med Ther. 2024; 24(1):400.

PMID: 39550552 PMC: 11568601. DOI: 10.1186/s12906-024-04689-7.


Difenoconazole Induced Damage of Bovine Mammary Epithelial Cells via ER Stress and Inflammatory Response.

Na M, Lee W, Park H Cells. 2024; 13(20.

PMID: 39451231 PMC: 11506304. DOI: 10.3390/cells13201715.


Network-based identification and mechanism exploration of active ingredients against Alzheimer's disease via targeting endoplasmic reticulum stress from traditional chinese medicine.

Dai Z, Hu T, Wei J, Wang X, Cai C, Gu Y Comput Struct Biotechnol J. 2024; 23:506-519.

PMID: 38261917 PMC: 10796977. DOI: 10.1016/j.csbj.2023.12.017.

References
1.
Bacci G, Briccoli A, Longhi A, Ferrari S, Mercuri M, Faggioli F . Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy. Acta Oncol. 2005; 44(7):748-55. DOI: 10.1080/02841860500327503. View

2.
Nakamura H, Takada K . Reactive oxygen species in cancer: Current findings and future directions. Cancer Sci. 2021; 112(10):3945-3952. PMC: 8486193. DOI: 10.1111/cas.15068. View

3.
Vundavilli H, Datta A, Sima C, Hua J, Lopes R, Bittner M . Anti-tumor effects of cryptotanshinone (CHO) in human osteosarcoma cell lines. Biomed Pharmacother. 2022; 150:112993. DOI: 10.1016/j.biopha.2022.112993. View

4.
Xin S, Wei G . Prognostic factors in osteosarcoma: A study level meta-analysis and systematic review of current practice. J Bone Oncol. 2020; 21:100281. PMC: 7047183. DOI: 10.1016/j.jbo.2020.100281. View

5.
Sun W, Wang B, Qu X, Zheng B, Huang W, Sun Z . Metabolism of Reactive Oxygen Species in Osteosarcoma and Potential Treatment Applications. Cells. 2020; 9(1). PMC: 7017125. DOI: 10.3390/cells9010087. View